⌘K

Home/Filings/4/0001171843-12-003705

4//SEC Filing

Capstone Therapeutics Corp. 4

Accession 0001171843-12-003705

$CAPSCIK 0000887151operating

View on SEC.gov Company Profile

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 5:15 PM ET

Size

7.2 KB

Accession

0001171843-12-003705

Insider Transaction Report

Form 4

Period: 2012-10-18

Capstone Therapeutics Corp.CAPS

HOLLIMAN JOHN M III

DirectorExecutive Chairman

Transactions

Purchase
Common Stock
2012-10-18$0.14/sh+100,000$14,000→ 432,614 total
Purchase
Common Stock
2012-10-19$0.14/sh+50,000$7,000→ 482,614 total

Holdings

Common Stock
(indirect: By Trust)
3,000
Common Stock
(indirect: Valley Ventures III, L.P.)
1,658

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Capstone Therapeutics Corp.

CIK 0000887151

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887151

Filing Metadata

Form type: 4
Filed: Oct 18, 8:00 PM ET
Accepted: Oct 19, 5:15 PM ET
Size: 7.2 KB

View on SEC.gov